• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Chmp

drugs 2025 2025 in pharma regulatory tracker pharma 2025
Pharma

Regulatory tracker: J&J's Tremfya picks up 2 pediatric FDA nods

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Fraiser Kansteiner , Zoey Becker , Angus Liu , Kevin Dunleavy , Eric Sagonowsky Sep 29, 2025 2:30pm
EMA CHMP Europe European Commission CHMP endorsement

EU regulators endorse meds from BMS, J&J, Eisai and more

Nov 15, 2024 10:05am
arrow back backwards u-turn turn around reverse

PTC gets another chance to keep Translarna's EU authorization

May 20, 2024 8:58am
Image of a neon sign with the word no lit up next to an unlit yes

Amylyx's ALS drug Albrioza rebuffed by EU regulator—again

Oct 13, 2023 11:24am
Mirati

Mirati's flagship KRAS inhibitor Krazati gets rebuffed in Europe

Jul 21, 2023 12:20pm
Novartis building

EU regulators recommend pulling Novartis sickle cell med Adakveo

May 26, 2023 11:18am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings